MEDICAL WEIGHT LOSS
Obesity is a complex, chronic condition that requires a multifaceted approach for effective management. Medical weight loss treatments go beyond diet and exercise, incorporating evidence-based therapies, behavioral modifications, and, when appropriate, prescription medications or surgical interventions. The goal is sustainable weight reduction to improve overall health and reduce the risk of associated conditions, such as diabetes, hypertension, and heart disease.
Medical Weight Loss Program
-
Lifestyle and Behavioral Changes:
-
Nutritional Counseling:
-
Customized meal plans focusing on calorie reduction, balanced macronutrients, and healthy eating habits.
-
-
Increased Exercise
-
Pharmacological Treatment Options:
-
Medications approved for weight management may be used when lifestyle changes alone are insufficient. These medications target appetite regulation, satiety, or fat absorption mechanisms.
-
-
Weight Loss Injections
Several FDA-approved medications are available for chronic weight management in patients with a body mass index (BMI) of 30 or higher, or 27 or higher with weight-related health conditions:
​​
-
GLP-1 Receptor Agonists (Semaglutide / Wegovy)
-
Mechanism: Mimic the GLP-1 hormone to regulate appetite and slow gastric emptying.
-
Benefits: Effective for significant weight loss and improving metabolic health.
-
Common Side Effects: Nausea, diarrhea, and constipation.
-
​
-
Dual GIP and GLP-1 Receptor Agonist (Tirzepatide / Zepbound)
-
Tirzepatide is the first medication to combine the effects of both GIP and GLP-1 receptor agonists:
-
GLP-1 Receptor Activation: Enhances insulin secretion, reduces glucagon levels, slows gastric emptying, and suppresses appetite.
-
GIP Receptor Activation: Improves insulin sensitivity and contributes to glucose control while also promoting satiety.
-
-
The dual-action mechanism provides a synergistic effect on blood sugar regulation and weight reduction, differentiating it from traditional GLP-1 therapies.
-
Common side effects are similar to those seen with GLP-1 receptor agonists and include:
-
Nausea
-
Vomiting
-
Diarrhea
-
Decreased appetite
-
-
​
​​
-
Rare but serious side effects may include pancreatitis or gallbladder disease. The medication is contraindicated for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
Support and Monitoring
​
-
Long-term success depends on regular follow-ups with your Top Shelf Healthcare provider, ongoing behavioral support, and adjustments to the treatment plan.
-
You will benefit from:
-
Accountability: Regular monitoring of progress.
-
Counseling: Identifying triggers and maintaining motivation.
-
Education: Empowering with strategies to maintain a healthy lifestyle.
-
​
​
Medical weight loss treatment provides a structured, scientifically-backed approach to managing obesity. It combines personalized lifestyle changes with medications to achieve sustainable weight loss and improve health outcomes.
Consulting a Top Shelf Healthcare provider is essential to determine the most appropriate treatment plan tailored to individual needs and medical history.
